Risperidone-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome-Reference-Cited by-同舟云学术

Risperidone-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome

Published:2017-02 Issue:1 Volume:37 Page:105-106
ISSN:1533-712X
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:J Clin Psychopharmacol

Author:

Look Mei Ling,Boo Yang Liang,Chin Pek Woon,Hoo Fan Kee

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference16 articles.

1. Risperidone versus placebo for schizophrenia;Cochrane Database Syst Rev,2010

2. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis;Lancet,2013

3. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity;J Clin Psychiatry,1994

4. New treatment guidelines for acute bipolar mania: a critical review;J Affect Disord,2012

5. Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children;Clin Med Insights Pediatr,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymptomatic COVID-19 Infection-Induced Rhabdomyolysis in the Backdrop of Statin-Cyclosporine Drug Interaction;Cureus;2024-08-29

2. Exceptionally high creatine kinase levels in risperidone-induced neuroleptic malignant syndrome: A case report;SAGE Open Medical Case Reports;2022-01

3. Paliperidonpalmitat-induzierte Rhabdomyolyse;neuropsychiatrie;2020-11-26

4. Rhabdomyolysis With Clozapine and Haloperidol Coadministration;Journal of Clinical Psychopharmacology;2020-08-20

5. Antipsychotic Drugs;Side Effects of Drugs Annual;2018